Carregant...
Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
Neuroendocrine prostate carcinoma, either co-present with the local adenocarcinoma disease or as a result of transdifferentiation later in time, was described as one major process of emerging resistance to androgen deprivation therapies, and at the clinical level it is consistent with the developmen...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4313607/ https://ncbi.nlm.nih.gov/pubmed/25699233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|